Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Jankowitz RC"'
Autor:
Singh SV, Kim SH, Sehrawat A, Arlotti JA, Hahm ER, Sakao K, Beumer JH, Jankowitz RC, Chandra-Kuntal K, Lee J, Powolny AA, Dhir R, Singh, Shivendra V, Kim, Su-Hyeong, Sehrawat, Anuradha, Arlotti, Julie A, Hahm, Eun-Ryeong, Sakao, Kozue, Beumer, Jan H, Jankowitz, Rachel C
Publikováno v:
JNCI: Journal of the National Cancer Institute; 2012 Aug 1, Vol. 104 Issue 16, p1228-1239, 12p
Publikováno v:
JNCI: Journal of the National Cancer Institute; Sep2011, Vol. 103 Issue 17, p1280-1282, 3p
Autor:
Tarantino P; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Tayob N; Harvard Medical School, Boston, MA.; Division of Data Science, Dana-Farber Cancer Institute, Boston, MA., Villacampa G; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Oncology Data Science Vall d'Hebron Institute of Oncology, Barcelona, Spain., Dang C; Memorial Sloan Kettering Cancer Center, New York, NY., Yardley DA; Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN., Isakoff SJ; Harvard Medical School, Boston, MA.; Massachusetts General Hospital, Boston, MA., Valero V; MD Anderson Cancer Center, Houston, TX., Faggen M; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Mulvey T; Harvard Medical School, Boston, MA.; Massachusetts General Hospital, Boston, MA., Bose R; Washington University School of Medicine, St Louis, MO., Weckstein D; New Hampshire Oncology Hematology, Manchester, NH., Wolff AC; Johns Hopkins Sidney Kimmel Cancer Center, Washington, DC., Reeder-Hayes K; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC., Rugo HS; University of California, San Francisco, CA., Ramaswamy B; Ohio State University Comprehensive Cancer Center, Columbus, OH., Zuckerman D; St Luke's Mountain States Tumor Institute, Boise, ID., Hart L; Wake Forest Baptist Health, Winston-Salem, NC., Gadi VK; University of Illinois Cancer Center, Chicago, IL., Constantine M; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Cheng K; North Shore-LIJ Cancer Institute, Lake Success, NY., Garrett AM; Northern Light Cancer Care, Brewer, ME., Marcom PK; Duke University School of Medicine, Durham, NC., Albain K; Loyola University Medical Center, Maywood, IL., DeFusco P; Hartford Healthcare Cancer Institute, Hartford, CT., Tung N; Harvard Medical School, Boston, MA.; Beth Israel Deaconess Medical Center, Boston, MA., Ardman B; Lowell General Hospital, Lowell, MA., Nanda R; UChicago Medicine, Chicago, IL., Jankowitz RC; Perelman Center for Advanced Medicine, Philadelphia, PA., Rimawi M; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX., Abramson V; Vanderbilt-Ingram Cancer Center, Nashville, TN., Pohlmann PR; MD Anderson Cancer Center, Houston, TX.; Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC., Van Poznak C; Rogel Cancer Center, University of Michigan, Ann Arbor, MI., Forero-Torres A; Kirklin UAB Hematology Oncology, Birmingham, AL., Liu MC; Natera, Inc, Austin, TX., Ruddy KJ; Mayo Clinic, Rochester, NY., Waks AG; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA., DeMeo M; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA., Burstein HJ; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA., Partridge AH; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA., Dell'Orto P; IEO European Institute of Oncology, IRCCS, Milan, Italy., Russo L; IEO European Institute of Oncology, IRCCS, Milan, Italy., Krause E; PathAI, Boston, MA., Newhouse DJ; NanoString Technologies, Inc, Boston, MA., Kurt BB; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA., Mittendorf EA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA.; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA., Schneider B; Indiana University School of Medicine, Indianapolis, IN., Prat A; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain., Winer EP; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA.; Yale Cancer Center, New Haven, CT., Krop IE; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA.; Yale Cancer Center, New Haven, CT., Tolaney SM; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Nov; Vol. 42 (31), pp. 3652-3665. Date of Electronic Publication: 2024 Jun 27.
Autor:
Oesterreich S; University of Pittsburgh, Department of Pharmacology and Chemical Biology, UPMC Hillman Cancer Center, Women's Cancer Research Center, Magee Womens Research Institute, Pittsburgh, PA, USA. oesterreichs@upmc.edu., Pate L; Independent ILC Advocate, Founder LBCA, Pittsburgh, PA, USA., Lee AV; University of Pittsburgh, Department of Pharmacology and Chemical Biology, UPMC Hillman Cancer Center, Women's Cancer Research Center, Magee Womens Research Institute, Pittsburgh, PA, USA.; Institute for Precision Medicine, University of Pittsburgh and UPMC, Pittsburgh, PA, USA., Chen F; University of Pittsburgh, Department of Pharmacology and Chemical Biology, UPMC Hillman Cancer Center, Women's Cancer Research Center, Magee Womens Research Institute, Pittsburgh, PA, USA.; Tsinghua University, Beijing, China., Jankowitz RC; University of Pennsylvania and Penn Medicine Abramson Cancer Center, Philadelphia, PA, USA., Mukhtar R; University of California, San Francisco, Department of Surgery, San Francisco, CA, USA., Metzger O; Dana Farber Cancer Institute, Department of Medical Oncology, Boston, MA, USA., Sikora MJ; Dept. of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Li CI; Fred Hutchinson Cancer Center, Division of Public Health Sciences, Seattle, WA, USA., Sotiriou C; Jules Bordet Institute Belgium, Brussels, Belgium., Shah OS; University of Pittsburgh, Department of Pharmacology and Chemical Biology, UPMC Hillman Cancer Center, Women's Cancer Research Center, Magee Womens Research Institute, Pittsburgh, PA, USA., Koorman T; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Ulaner G; Molecular Imaging and Therapy, Hoag Family Cancer Institute, Molecular Imaging and Therapy, Irvine, CA. Departments of Radiology and Translational Genomics, University of Southern California, Los Angeles, CA, USA., Reis-Filho JS; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; AstraZeneca, GAITHERSBURG, MARYLAND, USA., Davidson NM; Fred Hutchinson Cancer Center, Division of Public Health Sciences, Seattle, WA, USA., Van Baelen K; Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium., Hutcheson L; Lobular Breast Cancer Alliance Inc., White Horse Beach, MA, USA., Freeney S; Lobular Ireland, Dublin, Ireland., Migyanka F; Dynami Foundation, Wausau, WI, USA., Turner C; Lobular Breast Cancer UK, Nottingham, UK., Derksen P; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Bear T; Department of Family Medicine, University of Pittsburgh, Pittsburgh, patients/advocates, Pittsburgh, PA, USA., Desmedt C; Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium.
Publikováno v:
NPJ breast cancer [NPJ Breast Cancer] 2024 Jul 20; Vol. 10 (1), pp. 61. Date of Electronic Publication: 2024 Jul 20.
Autor:
Gradishar WJ; Robert H . Lurie Comprehensive Cancer Center of Northwestern University., Moran MS; Yale Cancer Center/Smilow Cancer Hospital., Abraham J; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute., Abramson V; Vanderbilt-Ingram Cancer Center., Aft R; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine., Agnese D; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute., Allison KH; Stanford Cancer Institute., Anderson B; University of Wisconsin Carbone Cancer Center., Bailey J; University of Michigan Rogel Cancer Center., Burstein HJ; Dana-Farber/Brigham and Women's Cancer Center., Chen N; The UChicago Medicine Comprehensive Cancer Center., Chew H; UC Davis Comprehensive Cancer Center., Dang C; Memorial Sloan Kettering Cancer Center., Elias AD; University of Colorado Cancer Center., Giordano SH; The University of Texas MD Anderson Cancer Center., Goetz MP; Mayo Clinic Comprehensive Cancer Center., Jankowitz RC; Abramson Cancer Center at the University of Pennsylvania., Javid SH; Fred Hutchinson Cancer Center., Krishnamurthy J; Fred & Pamela Buffett Cancer Center., Leitch AM; UT Southwestern Simmons Comprehensive Cancer Center., Lyons J; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute., McCloskey S; UCLA Jonsson Comprehensive Cancer Center., McShane M; Fox Chase Cancer Center., Mortimer J; City of Hope National Medical Center., Patel SA; Fox Chase Cancer Center., Rosenberger LH; Duke Cancer Institute., Rugo HS; UCSF Helen Diller Family Comprehensive Cancer Center., Santa-Maria C; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins., Schneider BP; Indiana University Melvin and Bren Simon Comprehensive Cancer Center., Smith ML; Research Advocacy Network., Soliman H; Moffitt Cancer Center., Stringer-Reasor EM; O'Neal Comprehensive Cancer Center at UAB., Telli ML; Stanford Cancer Institute., Wei M; Huntsman Cancer Institute at the University of Utah., Wisinski KB; University of Wisconsin Carbone Cancer Center., Yeung KT; UC San Diego Moores Cancer Center., Young JS; Roswell Park Comprehensive Cancer Center., Schonfeld R; National Comprehensive Cancer Network., Kumar R; National Comprehensive Cancer Network.
Publikováno v:
Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2024 Jul; Vol. 22 (5), pp. 331-357.
Autor:
Jacobs SA; NSABP Foundation, Pittsburgh, PA, USA. jacobssa1945@gmail.com., Wang Y; NSABP Foundation, Pittsburgh, PA, USA., Abraham J; NSABP Foundation, Pittsburgh, PA, USA.; Cleveland Clinic, Taussig Cancer Institute, Weston, Cleveland, OH, USA., Feng H; NSABP Foundation, Pittsburgh, PA, USA., Montero AJ; NSABP Foundation, Pittsburgh, PA, USA.; Cleveland Clinic, Taussig Cancer Institute, Weston, Cleveland, OH, USA.; University Hospitals/Seidman Cancer Center, Case Western Reserve University, Cleveland, OH, USA., Lipchik C; NSABP Foundation, Pittsburgh, PA, USA., Finnigan M; NSABP Foundation, Pittsburgh, PA, USA., Jankowitz RC; NSABP Foundation, Pittsburgh, PA, USA.; University of Pittsburgh, Pittsburgh, PA, USA.; University of Pennsylvania Perelman School of Medicine, State College, Philadelphia, PA, USA., Salkeni MA; NSABP Foundation, Pittsburgh, PA, USA.; National Institutes of Health, Washington, DC, USA.; Virginia Cancer Specialists, Fairfax, VA, USA., Maley SK; NSABP Foundation, Pittsburgh, PA, USA., Puhalla SL; NSABP Foundation, Pittsburgh, PA, USA.; UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Piette F; International Drug Development Institute, Louvain-la-Neuve, Belgium., Quinn K; Guardant Health, Redwood City, CA, USA., Chang K; Guardant Health, Redwood City, CA, USA., Nagy RJ; Guardant Health, Redwood City, CA, USA., Allegra CJ; NSABP Foundation, Pittsburgh, PA, USA.; University of Florida Health, Gainesville, FL, USA., Vehec K; NSABP Foundation, Pittsburgh, PA, USA., Wolmark N; NSABP Foundation, Pittsburgh, PA, USA.; UPMC Hillman Cancer Center, Pittsburgh, PA, USA., Lucas PC; NSABP Foundation, Pittsburgh, PA, USA.; UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Srinivasan A; NSABP Foundation, Pittsburgh, PA, USA.; Autism Impact Fund, Pittsburgh, PA, USA., Pogue-Geile KL; NSABP Foundation, Pittsburgh, PA, USA.
Publikováno v:
Breast cancer research : BCR [Breast Cancer Res] 2024 May 24; Vol. 26 (1), pp. 83. Date of Electronic Publication: 2024 May 24.
Autor:
Jacobs SA; NSABP Foundation, Pittsburgh, PA, USA. jacobssa1945@gmail.com., Wang Y; NSABP Foundation, Pittsburgh, PA, USA., Abraham J; NSABP Foundation, Pittsburgh, PA, USA.; Cleveland Clinic, Weston/Taussig Cancer Institute, Cleveland, OH, USA., Feng H; NSABP Foundation, Pittsburgh, PA, USA., Montero AJ; NSABP Foundation, Pittsburgh, PA, USA.; Cleveland Clinic, Weston/Taussig Cancer Institute, Cleveland, OH, USA.; University Hospitals/Seidman Cancer Center, Case Western Reserve University, Cleveland, OH, USA., Lipchik C; NSABP Foundation, Pittsburgh, PA, USA., Finnigan M; NSABP Foundation, Pittsburgh, PA, USA., Jankowitz RC; NSABP Foundation, Pittsburgh, PA, USA.; University of Pittsburgh, Pittsburgh, PA, USA.; University of Pennsylvania Perelman School of Medicine, State College, PA, USA., Salkeni MA; NSABP Foundation, Pittsburgh, PA, USA.; National Institutes of Health, Washington, DC, USA.; Virginia Cancer Specialists, Fairfax, VA, USA., Maley SK; NSABP Foundation, Pittsburgh, PA, USA., Puhalla SL; NSABP Foundation, Pittsburgh, PA, USA.; UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Piette F; International Drug Development Institute, Louvain-la-Neuve, Belgium., Quinn K; Guardant Health, Redwood City, CA, USA., Chang K; Guardant Health, Redwood City, CA, USA., Nagy RJ; Guardant Health, Redwood City, CA, USA., Allegra CJ; NSABP Foundation, Pittsburgh, PA, USA.; University of Florida Health, Gainesville, FL, USA., Vehec K; NSABP Foundation, Pittsburgh, PA, USA., Wolmark N; NSABP Foundation, Pittsburgh, PA, USA.; UPMC Hillman Cancer Center, Pittsburgh, PA, USA., Lucas PC; NSABP Foundation, Pittsburgh, PA, USA.; UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Srinivasan A; NSABP Foundation, Pittsburgh, PA, USA.; Autism Impact Fund, Pittsburgh, PA, USA., Pogue-Geile KL; NSABP Foundation, Pittsburgh, PA, USA.
Publikováno v:
Breast cancer research : BCR [Breast Cancer Res] 2024 Apr 22; Vol. 26 (1), pp. 69. Date of Electronic Publication: 2024 Apr 22.
Autor:
Van Baelen K; Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium.; Department of Gynecological Oncology, University Hospitals Leuven, Leuven, Belgium., Van Cauwenberge J; Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium.; Department of Gynecological Oncology, University Hospitals Leuven, Leuven, Belgium., Maetens M; Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium., Beck G; European Lobular Breast Cancer Consortium, Utrecht, the Netherlands., Camden A; Lobular Breast Cancer Alliance inc., Plymouth, MA, USA., Chase MC; Lobular Breast Cancer Alliance inc., Plymouth, MA, USA., Fraser V; Lobular Breast Cancer Alliance inc., Plymouth, MA, USA., Freeney S; European Lobular Breast Cancer Consortium, Utrecht, the Netherlands.; Lobular Ireland, Dublin, Ireland., Hutcheson L; Lobular Breast Cancer Alliance inc., Plymouth, MA, USA., Levine JK; Lobular Breast Cancer Alliance inc., Plymouth, MA, USA., Lien T; European Lobular Breast Cancer Consortium, Utrecht, the Netherlands., Terveer R; European Lobular Breast Cancer Consortium, Utrecht, the Netherlands.; Borstkankervereniging Nederland, Utrecht, the Netherlands., Turner C; European Lobular Breast Cancer Consortium, Utrecht, the Netherlands.; Lobular Breast Cancer UK, Manchester, UK., Senkus E; Department of Oncology and Radiotherapy, Medical University of Gdańsk, Gdańsk, Poland., Jankowitz RC; Division of Hematology/Oncology, Abramsom Cancer Center, University of Pennsylvania, Philadelphia, USA., Vandecaveye V; Department of Radiology, University Hospitals Leuven, Leuven, Belgium.; Division of Translational MRI, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium., Floris G; Department of Pathology, University Hospitals Leuven, Leuven, Belgium., Neven P; Department of Gynecological Oncology, University Hospitals Leuven, Leuven, Belgium., Wildiers H; Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium., Sawyer E; School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, Guy's Cancer Centre, King's College London, London, UK., Vincent-Salomon A; Department of Pathology, Institut Curie, Paris Sciences Lettres University, Paris, France., Derksen PWB; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands., Desmedt C; Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium. christine.desmedt@kuleuven.be.
Publikováno v:
NPJ breast cancer [NPJ Breast Cancer] 2024 Mar 20; Vol. 10 (1), pp. 23. Date of Electronic Publication: 2024 Mar 20.
Autor:
Sanft TB; 1Yale School of Medicine, New Haven, CT., Wong J; 2Biotheranostics, A Hologic Company, San Diego, CA., O'Neal B; 2Biotheranostics, A Hologic Company, San Diego, CA., Siuliukina N; 2Biotheranostics, A Hologic Company, San Diego, CA., Jankowitz RC; 3University of Pennsylvania, Philadelphia, PA., Pegram MD; 4Stanford Comprehensive Cancer Institute, Palo Alto, CA., Fox JR; 5Rocky Mountain Cancer Center, US Oncology, Boulder, CO., Zhang Y; 2Biotheranostics, A Hologic Company, San Diego, CA., Treuner K; 2Biotheranostics, A Hologic Company, San Diego, CA., O'Shaughnessy JA; 6Baylor University Medical Center, Texas Oncology, US Oncology, Dallas, TX.
Publikováno v:
Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2024 Mar 04; Vol. 22 (2), pp. 99-107. Date of Electronic Publication: 2024 Mar 04.
Autor:
Lenz L; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA., Neff C; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA., Solimeno C; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA., Cogan ES; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA., Abramson VG; Vanderbilt University Medical Center, Nashville, TN, USA., Boughey JC; Mayo Clinic, Rochester, MN, USA., Falkson C; University of Rochester Medical Center, Rochester, NY, USA., Goetz MP; Mayo Clinic, Rochester, MN, USA., Ford JM; Stanford University School of Medicine, Stanford, CA, USA., Gradishar WJ; Northwestern University, Chicago, IL, USA., Jankowitz RC; University of Pennsylvania, Philadelphia, PA, USA., Kaklamani VG; University of Texas Health Science Center at San Antonio, San Antonio, TX, USA., Marcom PK; Duke University, Durham, NC, USA., Richardson AL; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA., Storniolo AM; Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN, USA., Tung NM; Beth Israel Deaconess Medical Center, Boston, MA, USA., Vinayak S; University of Washington, Seattle, WA, USA.; Fred Hutchinson Cancer Research Center, 15. AstraZeneca, Seattle, WA, USA., Hodgson DR; AstraZeneca, Cambridge, UK., Lai Z; AstraZeneca, Boston, MA, USA., Dearden S; AstraZeneca, Cambridge, UK., Hennessy BT; Royal College of Surgeons in Ireland, Dublin, Ireland., Mayer EL; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Mills GB; Oregon Health & Science University, Portland, OR, USA., Slavin TP; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA., Gutin A; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA., Connolly RM; Cancer Research @UCC, University College Cork, Cork, Ireland., Telli ML; Stanford University School of Medicine, Stanford, CA, USA., Stearns V; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA., Lanchbury JS; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA., Timms KM; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA. ktimms@myriad.com.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2023 Nov; Vol. 202 (1), pp. 191-201. Date of Electronic Publication: 2023 Aug 17.